Module 2 - STOP HIV: Patient Huddle

Screen. Treat. Overcome. Prevent. S.T.O.P. HIV - Patient Huddle

Activity Details
  • Credit Amounts:
    • CME: 0.50
    • Other: 0.50
    • ANCC: 0.50
  • Cost: Free
  • Release: Sep 30, 2019
  • Expires: Apr 30, 2021
  • Estimated Time to Complete:
    30 Minutes
  • System Requirements:
  • Average User Rating:
    (6 Ratings)

Faculty

Keisa Fallin-Bennett Keisa Fallin-Bennett, MD, MPH
Associate Professor
Family and Community Medicine
University of Kentucky College of Medicine
Lexington, Kentucky

David Griffith David Griffith, MD
Clinical Associate
Division of Infectious Disease
Johns Hopkins School of Medicine
Baltimore, Maryland

Needs Statement

Individuals living with an unknown HIV infection account for approximately 40% of new HIV infections, due to a lack of screening (Webel AR, Longenecker CT, Gripshover B, et al., 2014). The CDC estimates that more than 50% of American adults of all ages have never been tested for HIV. Similar screening rates have been found for specific patient populations, such as men who have sex with men (MSM) and people who inject drugs (PWID), who have a higher risk of HIV infection. Effective HIV screening remains the most significant barrier to prevention and treatment. Therefore, there is a need for providers to place a greater emphasis to screen all patients over the age of 13 in an effort to prevent more new diagnoses and reduce transmission rates.

Target Audience

Primary Care Physicians, Nurse Practitioners, Physician Assistants, and Social Workers

Objectives

Upon completion of this activity, participants will be able to:

  • Assess barriers associated with HIV prevention methods, including safer sex practices and PrEP.
  • Identify barriers for initiating HIV prevention methods for PWID.
  • Discuss interventions that could prevent HIV transmission, such as safer needle use.

Accreditation

Medicine
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Kentucky College of Medicine, and DKBmed. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

ACGME Competencies - 
Medical knowledge


ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Joint Accreditation


In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and the University of Kentucky. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hour.

Other
UK Healthcare CECentral certifies this activity for 0.5 hour of participation.

 

 

Faculty Disclosure

No speakers, authors, planners or content reviewers have any relevant financial relationships to disclose.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Acknowledgment

The program is jointly provided by the University of Kentucky College of Medicine and DKBmed in collaboration with Postgraduate Institute for Medicine.

This activity is supported by an independent educational grant from Gilead Sciences, Inc.

CE Content Concerns

Policy

Concerns or complaints related to ACPE or ACCME standards may be submitted in writing to the Director of UK HealthCare CECentral by fax to 859-323-2920, or by mail to 2365 Harrodsburg Road, Ste B475, Lexington, KY 40504

Procedures

  • The Director or his/her designee will review, investigate, forward and/or respond to complaints and will put forth a best effort to adjudicate the issue(s), along with CECentral staff members, within two (2) weeks of receipt of the grievance or complaint.
  • If needed, concerns, complaints, or grievances will be brought before the UK HealthCare CECentral Advisory Board.
  • Issues regarding activity content also will be reviewed and addressed by the Activity Director.
  • A written decision will be issued in a timely manner by the Director of UK HealthCare CECentral or his/herdesignee.
  • Grievances will be considered when planning future activities.

Appeal Procedure

  • Persons who wish to appeal a decision should address the appeal by email, fax or in writing to the Director of UK HealthCare CECentral within two (2) weeks of receipt of the response.
  • The Director will bring the appeal to the UK HealthCare CECentral Advisory Board.
  • The results of the appeal will be sent to the participant no later than two (2) weeks following the meeting of the board.